Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification

Publication | Closed Access

DOI

Citations

References

2021

Year

Yan Wang, Fuhao Chu, Jie Lin, Yuan Li, Nadia Johnson, Jianglan Zhang, Cong Gai, Zeqi Su, Hong-Jie Cheng, Linheng Wang,

Journal of Ethnopharmacology

Network PharmacologyDendrobium Chrysotoxum LindlMedicinePharmacologyPathologyGastric CancerAnti-cancer AgentTumor SuppressorOncologyTumor MicroenvironmentCancer Research